Navigation Links
Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
Date:9/11/2007

Federal, State and Local Officials Scheduled to Attend Ceremony

CHESTER, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) announced that it will commemorate the 10th anniversary of its incorporation with a celebration for employees on Wednesday, Sept. 12, at Municipal Field (Gazebo Park) in Chester, New Jersey. Federal, state and local officials are scheduled to attend and participate in a ceremony recognizing Adams for its decade of success as a specialty pharmaceutical company focused on the treatment of respiratory disorders.

Adams, best known for its Mucinex(R) and Delsym(R) cough and cold products and the nationwide Mr. Mucus(TM) consumer advertising campaign, commenced operations in Fort Worth, Texas in September 1997. In April 2004, the Company relocated its corporate headquarters from Fort Worth to Chester, New Jersey. Adams currently employees nearly 500 people and its Chester facility houses more than 80 of its employees. The Company has expanded its headquarter operations twice since relocating to Chester in 2004 and doubled its portfolio of marketed respiratory products this year.

"On the occasion of this important milestone, I applaud our employees, whose talents and tireless efforts have fueled Adams' phenomenal growth in the past several years," said Michael J. Valentino, president & CEO. "I'm proud of our accomplishments and I look forward to a second decade of success with multiple new product introductions and our planned expansion into the prescription respiratory market."

"I congratulate Adams Respiratory Therapeutics on its 10-year anniversary, and the tremendous growth and success that this company has achieved in such a short period of time," said Stanley Kosierowski, COO and SVP business support, New Jersey Economic Development Authority, who is scheduled to attend the celebration on September 12. "It is New Jersey's good fortune to have companies like Adams come to our state, where they create jobs, become good neighbors and corporate citizens, and continue New Jersey's fine tradition of improving public health by providing important medicines for the entire nation."

In August 2007, Adams was named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Adams was ranked No. 7 overall, based on achieving a revenue growth rate of 1,638 percent from 2002 to 2006.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

For additional information about Adams, please visit the web site at http://www.adamsrt.com.


'/>"/>
SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Passive smoking affects respiratory system
2. Occupational exposurer aises respiratory symptoms
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Good News for New Borns With Hypoxic Respiratory Failure
6. Understanding The Link Between Hormone Replacement and Respiratory Disease
7. Hand sanitizers may reduce respiratory and gastrointestinal infections at home
8. Antibiotics for acute uncomplicated lower respiratory tract infection
9. Handwashing prevents diarrhea and acute lower respiratory infections
10. New Virus Held Responsible For Respiratory Infection In Children
11. Second Hand Exposure To Smoke In Childhood Can Cause Respiratory Problems Later
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... A new and improved Orgasm-Shot ... look and feel about themselves and their sexual encounters. A unique medical practice ... leakage head on with a ground breaking medical technique aimed to give women ...
(Date:6/26/2017)... ... 2017 , ... KICKICO , a protocol built on Ethereum for more ... catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will launch ... raising of funds through the power of many - has been around for about ...
(Date:6/25/2017)... ... ... lyric music video in Final Cut Pro X with ProLyric from Pixel Film Studios. Users ... to any song. ProLyric flies in the text for each section and it hovers around ... for optimal control. ProLyric makes editing any music video or text-based production easier than ever. ...
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the ... New Orleans. This is a new, greatly improved version of the Doctor Referral teaming ... requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... testing for medications in select Florida and Texas doctors' offices and clinics. This ... new application of genetic testing recognizes the role genes play in determining an ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)...  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company ... demonstrating positive biochemical outcomes related to more frequent hemodialysis ... will be presented at the ERA-EDTA Congress being held ... . The research was conducted by ... Europe (KIHDNEy) Cohort team ...
(Date:5/30/2017)... May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... today announced that it will be presenting at the 7th annual ... PT. Erez Raphael , CEO, of DarioHealth will be giving ... be held on June 6th & 7th, 2017 at the Luxe ... small / micro-cap space. About ...
(Date:5/30/2017)... Therapix Biosciences Ltd. (Nasdaq: TRPX), a ... development of cannabinoid-based drugs, today announced that the ... three upcoming scientific and investor conferences in June: ... ... Wednesday, June 7 ...
Breaking Medicine Technology: